戻る Agenda
Key Learnings from the First European Patient Advocacy Advisory Board for Leber’s Hereditary Optic Neurotherapy (LHON)
Session Chair(s)
Vanessa Dos Reis Ferreira, DrSc, MBA
Head Patient Advocacy Europe
Santhera Pharmaceuticals AG, Switzerland
Key learnings from the 1st European Patient Advocacy Advisory Board for Leber’s Hereditary Optic Neuropathy (LHON)